ArticleHematological oncology2022

CCR7 alterations associated with inferior outcome of adult T-cell leukemia/lymphoma under mogamulizumab treatment.

Yuma Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.